Literature DB >> 12240818

Microalbuminuria in diabetes mellitus.

Sheldon W Tobe1, Philip Alan McFarlane, David Malcolm Naimark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240818      PMCID: PMC121969     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  48 in total

1.  Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Authors:  M Ravid; D Brosh; D Ravid-Safran; Z Levy; R Rachmani
Journal:  Arch Intern Med       Date:  1998-05-11

Review 2.  Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs.

Authors:  A S Krolewski; J H Warram; M B Freire
Journal:  Endocrinol Metab Clin North Am       Date:  1996-06       Impact factor: 4.741

3.  Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. CODIAB-INSERM-ZENECA Pharma Study Group.

Authors:  C Delcourt; F Vauzelle-Kervroedan; G Cathelineau; L Papoz
Journal:  J Diabetes Complications       Date:  1998 Mar-Apr       Impact factor: 2.852

Review 4.  The impact of cardiovascular disease on people with diabetes: the potential for prevention.

Authors:  R C Eastman; H Keen
Journal:  Lancet       Date:  1997-07       Impact factor: 79.321

5.  Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension.

Authors:  G Berrut; B Bouhanick; P Fabbri; G Guilloteau; F Bled; J J Le Jeune; P Fressinaud; M Marre
Journal:  Clin Nephrol       Date:  1997-08       Impact factor: 0.975

6.  Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.

Authors: 
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

7.  The clinical course of renal function in NIDDM patients with normo- and microalbuminuria.

Authors:  S Nielsen; A Schmitz; M Rehling; C E Mogensen
Journal:  J Intern Med       Date:  1997-02       Impact factor: 8.989

8.  Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Authors:  M Ravid; D Brosh; Z Levi; Y Bar-Dayan; D Ravid; R Rachmani
Journal:  Ann Intern Med       Date:  1998-06-15       Impact factor: 25.391

9.  Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia. The Catalan Diabetic Nephropathy Study Group.

Authors:  E Esmatjes; C Castell; T Gonzalez; R Tresserras; G Lloveras
Journal:  Diabetes Res Clin Pract       Date:  1996-05       Impact factor: 5.602

Review 10.  Is antihypertensive treatment the same for NIDDM and IDDM patients?

Authors:  H H Parving
Journal:  Diabetes Res Clin Pract       Date:  1998-04       Impact factor: 5.602

View more
  7 in total

1.  Children are not small adults.

Authors:  Heather Dean; Elizabeth Sellers; Patricia Birk; Tom Blydt-Hansen; Malcolm Ogborn
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

2.  Role of the renin angiotensin system in diabetic nephropathy.

Authors:  Tanuj Chawla; Deepika Sharma; Archana Singh
Journal:  World J Diabetes       Date:  2010-11-15

3.  Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes.

Authors:  Ahmed A Mostafa; Edward W Randell; Sudesh C Vasdev; Vicki D Gill; Yingchun Han; Vereesh Gadag; Ahmed A Raouf; Hala El Said
Journal:  Mol Cell Biochem       Date:  2007-02-21       Impact factor: 3.396

4.  Physical activity alters urinary albumin/ creatinine ratio in type 1 diabetic patient.

Authors:  Ercan Tuncel; Erdinc Erturk; Canan Ersoy; Sinem Kiyici; Cevdet Duran; Nesrin Kuru; Sazi Imamoglu
Journal:  J Sports Sci Med       Date:  2004-03-01       Impact factor: 2.988

Review 5.  Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?

Authors:  Luis Ruilope; Joseph Izzo; Hermann Haller; Bernard Waeber; Suzanne Oparil; Michael Weber; George Bakris; James Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

6.  The association between anthropometric parameters, the metabolic syndrome and microalbuminuria in black Africans: the SABPA study.

Authors:  S Hoebel; J H de Ridder; L Malan
Journal:  Cardiovasc J Afr       Date:  2010 May-Jun       Impact factor: 1.167

7.  Nephroprotective effects of diacylglycerol on diabetic nephropathy in type 2 diabetic rats.

Authors:  Jianpeng Li; Yongheng Yan; Duo Li; Xia Li; Xinying Lin; Zhenhua Liu; Tongcheng Xu; Fangling Du
Journal:  Exp Ther Med       Date:  2017-12-18       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.